Fortuity Pharma is a public-benefit corporation dedicated to developing effective and affordable therapies for the rare disease community by repurposing existing drugs and nutraceuticals. Inspired by the story of Lucia, a patient with WOREE syndrome, the company was founded to bring the discontinued drug amlexanox back to market after it showed significant therapeutic potential in treating her condition caused by nonsense mutations leading to a premature termination codon. There is significant preclinical evidence this drug can read through premature stops during DNA translation to mRNA and then to protein synthesis in many rare diseases, so Fortuity Pharma is eager to leverage the established safety profile of this drug to develop effective treatments for patients with this genotype.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Genetic Mutations. Under The Guidance Of Their Physician
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.FortuityPharma.com
- Keywords
- Ft. Lauderdale.
Fortuity Pharma Questions
Fortuity Pharma's website is http://www.FortuityPharma.com
Fortuity Pharma's LinkedIn profile is https://www.linkedin.com/company/fortuity-pharma
Fortuity Pharma has
2 employees.
View email and phone details for 2
employees at Fortuity Pharma.
Fortuity Pharma's industry is
Pharmaceutical Manufacturing
Fortuity Pharma's top competitors are
Aspire Biosciences,
Thirtyfivebio,
Karp Asset Management,
Oncoheroes Biosciences,
Medics For Rare Disease,
Mica Ai Medical,
Migration Biotherapeutics Limited,
Bright Path Laboratories,
Third Street Digital,
Animantis.
Fortuity Pharma's categories are Pharmaceutical Manufacturing
Fortuity Pharma's founding year is 2024
